The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer

Autor: Epstein, JI, Amin, MB, Fine, SW, Algaba, F, Aron, M, Baydar, DE, Beltran, AL, Brimo, F, Cheville, JC, Colecchia, M, Comperat, E, da Cunha, IW, Delprado, W, DeMarzo, AM, Giannico, GA, Gordetsky, JB, Guo, CC, Hansel, DE, Hirsch, MS, Huang, JT, Humphrey, PA, Jimenez, RE, Khani, F, Kong, QN, Kryvenko, ON, Kunju, LP, Lal, P, Latour, M, Lotan, T, Maclean, F, Magi-Galluzzi, C, Mehra, R, Menon, S, Miyamoto, H, Montironi, R, Netto, GJ, Nguyen, JK, Osunkoya, AO, Parwani, A, Robinson, BD, Rubin, MA, Shah, RB, So, JS, Takahashi, H, Tavora, F, Tretiakova, MS, True, L, Wobker, SE, Yang, XMJ, Zhou, M, Zynger, DL, Trpkov, K

Publikováno v: ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Context.-Controversies and uncertainty persist in prostate cancer grading. prostate cancer grading. Objective.-To update grading recommendations Data Sources.-Critical review of the literature along with pathology and clinician surveys. Conclusions.-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::76c321c06ce974534b3f9b7f1511bbfa
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4835

Acceptance of emerging renal oncocytic neoplasms: a survey of urologic pathologists.

Autor: Mohanty SK; Department of Pathology, Advanced Medical Research Institute Hospital, Kolkata, India.; Department of Pathology, Core Diagnostics, Gurgaon, India., Lobo A; Department of Pathology, Kapoor Center of Urology and Pathology, Raipur, India., Jha S; Department of Pathology, Advanced Medical Research Institute Hospital, Kolkata, India., Sangoi AR; Department of Pathology, El Camino Hospital, Mountain View, USA., Akgul M; Department of Pathology, Albany Medical Centre, Albany, USA., Trpkov K; Department of Pathology, University of Calgary, Calgary, Canada., Hes O; Department of Pathology, Bioptika Laborator S.R.O, Pilsen, Czech Republic., Mehra R; Department of Pathology, University of Michigan, Ann Arbor, USA., Hirsch MS; Department of Pathology, Brigham and Women's Hospital, Boston, USA., Moch H; Department of Pathology, University Hospital, Zurich, Switzerland., Smith SC; Department of Pathology, Virginia Commonwealth University School of Medicine, Richmond, USA., Shah RB; Department of Pathology, UT Southwestern Medical Center, Dallas, USA., Cheng L; Department of Pathology, Brown University, Providence, USA., Amin MB; Department of Pathology, The University of Tennessee Health Science Center, Memphis, USA., Epstein JI; IMP Pathology, Garden City, USA., Parwani AV; Department of Pathology, Ohio State University, Columbus, USA., Delahunt B; Department of Pathology, Wellington School/Medicine, Wellington, New Zealand., Desai S; Department of Pathology, Tata Memorial Hospital, Mumbai, India., Przybycin CG; Department of Pathology, Cleveland Clinic, Cleveland, USA., Manini C; Department of Pathology, University of Turin, Turin, Italy., Luthringer DJ; Department of Pathology, Cedars-Sinai Medical Center, Los Angeles, USA., Sirohi D; Department of Pathology, University of Utah/ARUP, Salt Lake City, USA., Jain D; Department of Pathology, Core Diagnostics, Gurgaon, India., Midha D; Department of Pathology, Tata Medical Center, Kolkata, India., Jain E; Department of Pathology, Core Diagnostics, Gurgaon, India., Maclean F; Department of Pathology, Douglass Hanly Moir Pathology, Sydney, Australia., Giannico GA; Department of Pathology, Vanderbilt University Medical Center, Nashville, USA., Paner GP; Department of Pathology, University of Chicago, Chicago, USA., Martignoni G; Department of Pathology, University of Verona, Verona, Italy., Al-Ahmadie HA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA., McKenney J; Department of Pathology, Cleveland Clinic, Cleveland, USA., Srigley JR; Department of Pathology, Trillium Health Partners, Credit Valley Hospital, Mississauga, Canada., Lopez JI; Department of Pathology, Cruces University Hospital, Barakaldo, Spain., Kunju LP; Department of Pathology, University of Michigan, Ann Arbor, USA., Browning L; Department of Pathology, Oxford University Hospital NHS Foundation Trust, Oxford, UK., Aron M; Department of Pathology, Keck School of Medicine of USC, Los Angeles, USA., Picken MM; Department of Pathology, Loyola University Medical Center, Maywood, USA., Tretiakova M; Department of Pathology, University of Washington, Seattle, USA., Zhou M; Department of Pathology, Tufts University School of Medicine, Boston, USA., Sable M; Department of Pathology, All India Institute of Medical Sciences, Bhubaneswar, India., Kuroda N; Department of Pathology, Kochi Red Cross Hospital, Kochi City, Kochi, Japan., Pattnaik N; Department of Pathology, Advanced Medical Research Institute Hospital, Kolkata, India., Gupta NS; Department of Pathology, Henry Ford Health System, Detroit, USA., Rao P; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA., Fine SW; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA., Mishra P; Department of Pathology, All India Institute of Medical Sciences, Bhubaneswar, India., Adhya AK; Department of Pathology, All India Institute of Medical Sciences, Bhubaneswar, India., Kulkarni BN; Department of Pathology, Kokilaben Ambani Hospital, Mumbai, India., Dixit M; Department of Pathology, Core Diagnostics, Gurgaon, India., Baisakh MR; Department of Pathology, Apollo Hospitals Bhubaneshwar, Bhubaneswar, India., Arora S; Department of Pathology, Core Diagnostics, Gurgaon, India., Sancheti S; Department of Pathology, Homi Bhabha Cancer Center, Visakhapatnam, India., Menon S; Department of Pathology, Tata Memorial Hospital, Mumbai, India., Wobker SE; Department of Pathology, The University of North Carolina at Chapel Hill, Chapel Hill, USA., Tickoo SK; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA., Kaushal S; Department of Pathology, All India Institute of Medical Sciences, New Delhi, India., Soni S; Department of Pathology, Muljibhai Patel Urological Hospital, Nadiad, India., Kandukuri S; Department of Pathology, Keck School of Medicine of USC, Los Angeles, USA., Sharma S; Department of Pathology, Core Diagnostics, Gurgaon, India., Mitra S; Department of Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India., Reuter VE; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA., Malik V; Department of Pathology, Core Diagnostics, Gurgaon, India., Rao V; Department of Pathology, Basavatakaram Indo-American Cancer Hospital and Research Institute, Hyderabad, India., Chen YB; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA., Williamson SR; Department of Pathology, Cleveland Clinic, Cleveland, USA. willias73@ccf.org.

Publikováno v: Virchows Archiv : an international journal of pathology [Virchows Arch] 2024 Nov; Vol. 485 (5), pp. 829-840. Date of Electronic Publication: 2024 Sep 17.

Associations of prostate tumor immune landscape with vigorous physical activity and prostate cancer progression.

Autor: Huang L; Queen's University Belfast, Belfast, United Kingdom., Winter SJ; Queen's University Belfast, Belfast, United Kingdom., Olsson LT; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States., Hamilton AM; University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Halliday SR; Queen's University Belfast, Belfast, United Kingdom., Kirk EL; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States., Farnan L; University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Gerstel A; University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Craig SG; Queen's University Belfast, United Kingdom., Finn SP; Trinity College Dublin, Dublin, Ireland., LaBonte Wilson M; Queen's University Belfast, Belfast, United Kingdom., Jain S; Queen's University Belfast, Belfast, United Kingdom., Troester MA; University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Butler EN; University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Bensen JT; University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Wobker SE; University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Allott EH; Queen's University Belfast, Belfast, United Kingdom.

Publikováno v: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2024 Sep 13. Date of Electronic Publication: 2024 Sep 13.

Decisional Conflict Among Patients Newly Diagnosed With Clinical T1 Renal Masses: A Prospective Study.

Autor: Feinberg A; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Gessner KH; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Deal AM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Heiling HM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Myers S; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Raynor MC; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Milowsky MI; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Wobker SE; Department of Pathology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Commander CW; Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Lazard AJ; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Hussman School of Journalism and Media, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Bjurlin MA; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Smith AB; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Johnson DC; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Wallen EM; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Kim WY; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Tan HJ; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Publikováno v: The Journal of urology [J Urol] 2024 Aug; Vol. 212 (2), pp. 320-330. Date of Electronic Publication: 2024 May 08.

Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer.

Autor: Beckabir W; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Department of Microbiology and Immunology, UNC School of Medicine, Chapel Hill, NC, USA., Zhou M; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Lee JS; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Curriculum in Bioinformatics and Computational Biology, UNC School of Medicine, Chapel Hill, NC, USA., Vensko SP; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Woodcock MG; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Wang HH; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Department of Microbiology and Immunology, UNC School of Medicine, Chapel Hill, NC, USA., Wobker SE; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Atassi G; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Wilkinson AD; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Fowler K; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Flick LM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Damrauer JS; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Harrison MR; Division of Medical Oncology, Department of Medicine, Duke Cancer Institute, Duke University, Durham, NC, USA., McKinnon KP; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Department of Microbiology and Immunology, UNC School of Medicine, Chapel Hill, NC, USA., Rose TL; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Milowsky MI; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Serody JS; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. jonathan_serody@med.unc.edu.; Department of Microbiology and Immunology, UNC School of Medicine, Chapel Hill, NC, USA. jonathan_serody@med.unc.edu.; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. jonathan_serody@med.unc.edu.; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. jonathan_serody@med.unc.edu., Kim WY; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. wykim@med.unc.edu.; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. wykim@med.unc.edu.; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. wykim@med.unc.edu.; Division of Hematology, Department of Medicine, UNC School of Medicine, Chapel Hill, NC, USA. wykim@med.unc.edu., Vincent BG; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. benjamin_vincent@med.unc.edu.; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. benjamin_vincent@med.unc.edu.; Curriculum in Bioinformatics and Computational Biology, UNC School of Medicine, Chapel Hill, NC, USA. benjamin_vincent@med.unc.edu.; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. benjamin_vincent@med.unc.edu.; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. benjamin_vincent@med.unc.edu.; Computational Medicine Program, UNC School of Medicine, Chapel Hill, NC, USA. benjamin_vincent@med.unc.edu.

Publikováno v: Nature communications [Nat Commun] 2024 May 24; Vol. 15 (1), pp. 4448. Date of Electronic Publication: 2024 May 24.